Perveen Mahmoodah MD - Bayonne, New Jersey 07002

Perveen Mahmoodah MD is categorized under Doctors in Bayonne, NJ .

Business Name: Perveen Mahmoodah MD
Contact Person: Mahmoodah Perveen
Address: 534 Avenue East # D, Bayonne, New Jersey 07002
Phone Number: (201) 858-8700
Annual Revenue (USD): $500.000 to $999.999
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Doctors
SIC Code: 8011
NAICS Code: 6211110
Share This Business:
Related Businesses: Kelly Lenore MD - Bayonne, NJ 07002
Dmitry Khasak MD - Bayonne, NJ 07002
Pelosi III Marco MD - Bayonne, NJ 07002
Vintayen Enrico V MD - Bayonne, NJ 07002
Tarng George W MD - Bayonne, NJ 07002
Jaspal Sunjit S MD - Bayonne, NJ 07002
Hanna Mamdouh MD - Bayonne, NJ 07002
Garcia Pallaviccin MD - Bayonne, NJ 07002
Schehr-Kimble Danielle J MD - Bayonne, NJ 07002
Hanify Katherine A DO - Bayonne, NJ 07002
Raafat Ghobraiel MD - Bayonne, NJ 07002
Buchen Daniel MD - Bayonne, NJ 07002
Shulman Elliot MD - Bayonne, NJ 07002
Thaker-Jayeshk Jayeshkumar MD - Bayonne, NJ 07002
Marks Lloyd MD - Bayonne, NJ 07002
Marc W Urquhart Md - Bayonne, NJ 07002
Malalis Carmelita MD - Bayonne, NJ 07002
Mc Gee John R MD - Bayonne, NJ 07002
Rubino Robert J MD - Bayonne, NJ 07002
Diaz Frank J MD - Bayonne, NJ 07002

The company Perveen Mahmoodah MD provides B2C services in the form of Doctors from its single location in New Jersey. 1 to 4 employees work for Perveen Mahmoodah MD, and the business now earns $500.000 to $999.999 per annum.

Perveen Mahmoodah MD was launched in 0 and is classified under SIC code and category 8011 , and NAICS number and grouping 6211110 . To contact Perveen Mahmoodah MD, please call Mahmoodah Perveen with the phone number (201) 858-8700 or visit its single location at 534 Avenue East # D in Bayonne, New Jersey 07002.

The location of the single location can also be found using the coordinates 40.67182,-74.1082. Read more details about this business on the webpage or follow the company’s social media accounts, on Twitter and on Facebook.